Ask
Search
My library
ORKG

ORKG Ask

Our mission is to organize scholarly knowledge and make it accessible to humans and machines.

About

About ORKG Ask
Report issue
Statistics
Contact

Legal

Terms of use
Data protection (sheet)
Imprint
Accessibility
License

Technical

We
open source
System status
Changelog
Frontend: v1.41.0
Backend: v1.13.4

We use cookies to provide a better user experience.

Data Protection

Malignant Lymphomas Efficacy of vinorelbine, epirubicin and

Pier Luigi Zinzani
Monica Tani
Vittorio Stefoni
Patrizia Albertini
Maurizio Bendandi
Filippo Gherlinzoni
Lapo Alinari
Ernesto Vigna

Publication date

September 2016

Abstract

prednisone combination regimen in pretreated elderly patients with aggressive non-Hodgkin’s lymphom

Extracted data

Related items

VNCOP-B plus rituximab in the treatment of diffuse large B-cell lymphoma in the elderly

M. Fina
M. Tani
V. Stefoni
G. Musuraca
E. Marchi
C. Pellegrini
L. Alinari
E. Derenzini
F. Bacci
S. Pileri
M. Baccarani
P.L. Zinzani

January 2007

The conventional treatment included CHOP and several age-adapted regimens, from first to third gener...

Activity and Safety of Dose-Adjusted Infusional Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Chemotherapy With Rituximab in Very Elderly Patients With Poor-Prognostic Untreated Diffuse Large B-Cell Non-Hodgkin Lymphoma

June 2017

none7BACKGROUND: This study was designed to assess the activity and safety of dose-adjusted infusion...

Treatment of Advanced Malignant LymphomaPart 1. Combination Chemotherapy for Advanced Non Hodgkin's Lymphoma with Adriamycin, Vincristine, Ifosfamide, and Prednisolone.

Ueoka, Hiroshi

April 1985

Twenty-nine patients with advanced non-Hodgkin's lymphoma (3 with follicular medium-sized cell type,...

Low-dose epirubicin in combination with cyclophosphamide, vinblastine and prednisone (mini-CEOP) for the treatment of aggressive non-Hodgkin’s lymphoma in elderly patients.

D. VENERI
F. ZANETTI
M. FRANCHINI
G. PIZZOLO
KRAMPERA, Mauro

January 2002

Low-dose epirubicin in combination with cyclophosphamide, vinblastine and prednisone (mini-CEOP) for...

Cyclophosphamide, pegylated liposomal doxorubicin, vincristine and prednisone (CDOP) plus rituximab is effective and well tolerated in poor performance status elderly patients with non-Hodgkin's lymphoma.

July 2015

none12noneVisani G; Guiducci B; D'Adamo F; Mele A; Nicolini G; Leopardi G; Sparaventi G; Barulli S; ...

Cyclophosphamide, doxorubicin, vincristine, prednisone and rituximab versus epirubicin, cyclophosphamide, vinblastine, prednisone and rituximab for the initial treatment of elderly “fit” patients with diffuse large B-cell lymphoma: results from the ANZINTER3 trial of the Intergruppo Italiano Linfomi

Merli F.
Rossi G.
Tucci A.
Ilariucci F.
Chiappella A.
Musso M.
Di Rocco A.
Stelitano C.
Alvarez I.
Baldini L.
Mazza P.
Salvi F.
Arcari A.
Fragasso A.
Gobbi P. G.
Liberati A. M.
LUMINARI, Stefano
MAMMI, Caterina
MARCHESELLI, Luigi
FEDERICO, Massimo

January 2012

We conducted a prospective study to compare epirubicin, cyclophosphamide, vinblastine, prednisone an...

Alternating chemotherapy regimen (P-VABEC) for intermediate and high-grade non-Hodgkin's lymphoma of the middle aged and elderly.

Caracciolo F
PETRINI, MARIO
Capochiani E
PAPINESCHI, FEDERICO
Grassi B.
CARULLI, GIOVANNI

January 1994

An intensive third generation regimen (P-VABEC) including adriamycin, etoposide, cyclophosphamide, v...

Cyclophosphamide, doxorubicin, vincristine, prednisone and rituximab versus epirubicin, cyclophosphamide, vinblastine, prednisone and rituximab for the initial treatment of elderly fit patients with diffuse large B-cell lymphoma : results from the ANZINTER3 trial of the Intergruppo italiano linfomi

F. Merli
S. Luminari
G. Rossi
C. Mammi
L. Marcheselli
A. Tucci
F. Ilariucci
A. Chiappella
M. Musso
A. Di Rocco
C. Stelitano
I. Alvarez
L. Baldini
P. Mazza
F. Salvi
A. Arcari
A. Fragasso
P. Gobbi
A. Liberati
M. Federico

April 2012

We conducted a prospective study to compare epirubicin, cyclophosphamide, vinblastine, prednisone an...

Durable response after VNCOP-B and rituximab in an elderly patient with high-grade B-cell lymphoma

Cencini, Emanuele
Fabbri, Alberto
Schiattone, Luana
Gentili, Francesco
Mazzei, Maria Antonietta
Bocchia, Monica

January 2018

Objectives and Methods:Â High-grade B-cell lymphoma, NOS (HGBL) have an aggressive clinical behavior...

Remarkable Remission Rate and Long-Term Efficacy of Upfront Metronomic Chemotherapy in Elderly and Frail Patients, with Diffuse Large B-Cell Lymphoma

Guido Bocci
Sabrina Pelliccia
Paola Orlandi
Matteo Caridi
Marta Banchi
Gerardo Musuraca
Arianna Di Napoli
Maria Paola Bianchi
Caterina Patti
Paola Anticoli-Borza
Roberta Battistini
Ivana Casaroli
Tiziana Lanzolla
Agostino Tafuri
Maria Christina Cox

December 2022

The upfront treatment of very elderly and frail patients with diffuse large B-cell lymphoma (DLBCL) ...

VNCOP-B regimen in the treatment of high-grade non-Hodgkin's lymphoma in the elderly

Zinzani, P L
Bendandi, M
Gherlinzoni, F
Mazza, P
Salvucci, M
Aitini, E
Miggiano, M C
Gozzetti, A
Tura, S

January 1993

Background. Age is an important factor, especially in patients with advanced lymphoma who require mo...

Elderly aggressive-histology non-Hodgkin's lymphoma: first-line VNCOP-B regimen experience on 350 patients.

Zinzani PL
Storti S
Zaccaria A
Moretti L
Magagnoli M
Pavone E
Gentilini P
Guardigni L
Gobbi M
Fattori PP
Falini B
Lauta VM
Bendandi M
Gherlinzoni F
De Renzo A
Zaja F
Mazza P
Volpe E
Bocchia M
Aitini E
Tabanelli M
Leone G
Tura S.

January 1999

Age is a risk factor and a prognostic parameter in elderly aggressive-histology non-Hodgkin's lympho...

des Lymphomes de l'Adulte

Service De Medecine A
Chu Brabois
Oeuvn-lis-nancy Service D&apos
Hopital Henri Mondor
Creteil Service
Hopital Universitairc Dupuytren
Hopital Edouard Herriot
Centre Henri Becquerel
Rouen Service De Cancerologie
Centre Hospitalier
Rene Dubos

October 2016

Effect of granulocyte colony-stimulating factor administration in elderly patients with aggressive n...

Non-anthracycline chemotherapy associated with a poor outcome in elderly Egyptian patients with diffuse large B-cell non-Hodgkin lymphoma

Zeeneldin, Ahmed A.
Sallam, Yasser A.
Gaber, Ayman A.
Shaheen, Amgad A.

July 2015

Aim: Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) is the standar...

VNCOP-B plus rituximab in the treatment of diffuse large B-cell lymphoma in the elderly.

July 2015

none12The conventional treatment included CHOP and several age-adapted regimens, from first to third...

VNCOP-B plus rituximab in the treatment of diffuse large B-cell lymphoma in the elderly

M. Fina
M. Tani
V. Stefoni
G. Musuraca
E. Marchi
C. Pellegrini
L. Alinari
E. Derenzini
F. Bacci
S. Pileri
M. Baccarani
P.L. Zinzani

January 2007

The conventional treatment included CHOP and several age-adapted regimens, from first to third gener...

Activity and Safety of Dose-Adjusted Infusional Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Chemotherapy With Rituximab in Very Elderly Patients With Poor-Prognostic Untreated Diffuse Large B-Cell Non-Hodgkin Lymphoma

June 2017

none7BACKGROUND: This study was designed to assess the activity and safety of dose-adjusted infusion...

Treatment of Advanced Malignant LymphomaPart 1. Combination Chemotherapy for Advanced Non Hodgkin's Lymphoma with Adriamycin, Vincristine, Ifosfamide, and Prednisolone.

Ueoka, Hiroshi

April 1985

Twenty-nine patients with advanced non-Hodgkin's lymphoma (3 with follicular medium-sized cell type,...

Low-dose epirubicin in combination with cyclophosphamide, vinblastine and prednisone (mini-CEOP) for the treatment of aggressive non-Hodgkin’s lymphoma in elderly patients.

D. VENERI
F. ZANETTI
M. FRANCHINI
G. PIZZOLO
KRAMPERA, Mauro

January 2002

Low-dose epirubicin in combination with cyclophosphamide, vinblastine and prednisone (mini-CEOP) for...

Cyclophosphamide, pegylated liposomal doxorubicin, vincristine and prednisone (CDOP) plus rituximab is effective and well tolerated in poor performance status elderly patients with non-Hodgkin's lymphoma.

July 2015

none12noneVisani G; Guiducci B; D'Adamo F; Mele A; Nicolini G; Leopardi G; Sparaventi G; Barulli S; ...

Cyclophosphamide, doxorubicin, vincristine, prednisone and rituximab versus epirubicin, cyclophosphamide, vinblastine, prednisone and rituximab for the initial treatment of elderly “fit” patients with diffuse large B-cell lymphoma: results from the ANZINTER3 trial of the Intergruppo Italiano Linfomi

Merli F.
Rossi G.
Tucci A.
Ilariucci F.
Chiappella A.
Musso M.
Di Rocco A.
Stelitano C.
Alvarez I.
Baldini L.
Mazza P.
Salvi F.
Arcari A.
Fragasso A.
Gobbi P. G.
Liberati A. M.
LUMINARI, Stefano
MAMMI, Caterina
MARCHESELLI, Luigi
FEDERICO, Massimo

January 2012

We conducted a prospective study to compare epirubicin, cyclophosphamide, vinblastine, prednisone an...

Alternating chemotherapy regimen (P-VABEC) for intermediate and high-grade non-Hodgkin's lymphoma of the middle aged and elderly.

Caracciolo F
PETRINI, MARIO
Capochiani E
PAPINESCHI, FEDERICO
Grassi B.
CARULLI, GIOVANNI

January 1994

An intensive third generation regimen (P-VABEC) including adriamycin, etoposide, cyclophosphamide, v...

Cyclophosphamide, doxorubicin, vincristine, prednisone and rituximab versus epirubicin, cyclophosphamide, vinblastine, prednisone and rituximab for the initial treatment of elderly fit patients with diffuse large B-cell lymphoma : results from the ANZINTER3 trial of the Intergruppo italiano linfomi

F. Merli
S. Luminari
G. Rossi
C. Mammi
L. Marcheselli
A. Tucci
F. Ilariucci
A. Chiappella
M. Musso
A. Di Rocco
C. Stelitano
I. Alvarez
L. Baldini
P. Mazza
F. Salvi
A. Arcari
A. Fragasso
P. Gobbi
A. Liberati
M. Federico

April 2012

We conducted a prospective study to compare epirubicin, cyclophosphamide, vinblastine, prednisone an...

Durable response after VNCOP-B and rituximab in an elderly patient with high-grade B-cell lymphoma

Cencini, Emanuele
Fabbri, Alberto
Schiattone, Luana
Gentili, Francesco
Mazzei, Maria Antonietta
Bocchia, Monica

January 2018

Objectives and Methods:Â High-grade B-cell lymphoma, NOS (HGBL) have an aggressive clinical behavior...

Remarkable Remission Rate and Long-Term Efficacy of Upfront Metronomic Chemotherapy in Elderly and Frail Patients, with Diffuse Large B-Cell Lymphoma

Guido Bocci
Sabrina Pelliccia
Paola Orlandi
Matteo Caridi
Marta Banchi
Gerardo Musuraca
Arianna Di Napoli
Maria Paola Bianchi
Caterina Patti
Paola Anticoli-Borza
Roberta Battistini
Ivana Casaroli
Tiziana Lanzolla
Agostino Tafuri
Maria Christina Cox

December 2022

The upfront treatment of very elderly and frail patients with diffuse large B-cell lymphoma (DLBCL) ...

VNCOP-B regimen in the treatment of high-grade non-Hodgkin's lymphoma in the elderly

Zinzani, P L
Bendandi, M
Gherlinzoni, F
Mazza, P
Salvucci, M
Aitini, E
Miggiano, M C
Gozzetti, A
Tura, S

January 1993

Background. Age is an important factor, especially in patients with advanced lymphoma who require mo...

Elderly aggressive-histology non-Hodgkin's lymphoma: first-line VNCOP-B regimen experience on 350 patients.

Zinzani PL
Storti S
Zaccaria A
Moretti L
Magagnoli M
Pavone E
Gentilini P
Guardigni L
Gobbi M
Fattori PP
Falini B
Lauta VM
Bendandi M
Gherlinzoni F
De Renzo A
Zaja F
Mazza P
Volpe E
Bocchia M
Aitini E
Tabanelli M
Leone G
Tura S.

January 1999

Age is a risk factor and a prognostic parameter in elderly aggressive-histology non-Hodgkin's lympho...

des Lymphomes de l'Adulte

Service De Medecine A
Chu Brabois
Oeuvn-lis-nancy Service D&apos
Hopital Henri Mondor
Creteil Service
Hopital Universitairc Dupuytren
Hopital Edouard Herriot
Centre Henri Becquerel
Rouen Service De Cancerologie
Centre Hospitalier
Rene Dubos

October 2016

Effect of granulocyte colony-stimulating factor administration in elderly patients with aggressive n...

Non-anthracycline chemotherapy associated with a poor outcome in elderly Egyptian patients with diffuse large B-cell non-Hodgkin lymphoma

Zeeneldin, Ahmed A.
Sallam, Yasser A.
Gaber, Ayman A.
Shaheen, Amgad A.

July 2015

Aim: Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) is the standar...

VNCOP-B plus rituximab in the treatment of diffuse large B-cell lymphoma in the elderly.

July 2015

none12The conventional treatment included CHOP and several age-adapted regimens, from first to third...

VNCOP-B plus rituximab in the treatment of diffuse large B-cell lymphoma in the elderly

M. Fina
M. Tani
V. Stefoni
G. Musuraca
E. Marchi
C. Pellegrini
L. Alinari
E. Derenzini
F. Bacci
S. Pileri
M. Baccarani
P.L. Zinzani

January 2007

The conventional treatment included CHOP and several age-adapted regimens, from first to third gener...

Activity and Safety of Dose-Adjusted Infusional Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Chemotherapy With Rituximab in Very Elderly Patients With Poor-Prognostic Untreated Diffuse Large B-Cell Non-Hodgkin Lymphoma

June 2017

none7BACKGROUND: This study was designed to assess the activity and safety of dose-adjusted infusion...

Treatment of Advanced Malignant LymphomaPart 1. Combination Chemotherapy for Advanced Non Hodgkin's Lymphoma with Adriamycin, Vincristine, Ifosfamide, and Prednisolone.

Ueoka, Hiroshi

April 1985

Twenty-nine patients with advanced non-Hodgkin's lymphoma (3 with follicular medium-sized cell type,...